Fauré Régis, Shiao Tze Chieh, Lagnoux David, Giguère Denis, Roy René
Equipe PharmaQAM, Département de Chimie, Université du Québec a Montréal, P.O. Box 8888, Succ. Centre-Ville, H3C 3P8 Montréal, Québec, Canada.
Org Biomol Chem. 2007 Aug 21;5(16):2704-8. doi: 10.1039/b708365c.
We report a very high yielding first total synthesis of trisaccharide 5, alpha-D-Rhap-(1 --> 3)-alpha-D-Rhap-(1 --> 4)-alpha-D-Galp, corresponding to the repeating unit 1 of an O-polysaccharide present in the lipopolysaccharide of clinical isolate of Burkholderia cepacia. The approach included two successive glycosylations, based on D-rhamnosyl trichloroacetimidate donors 12 and 14. The oligosaccharide 5 has been further functionalized by photochemical coupling or cross-metathesis with non-natural amino acid derivatives. Trisaccharidylamino acids 16 and 17 are now available, with the aim of preparing a novel synthetic carbohydrate-based vaccine.
我们报道了三糖5,α-D-鼠李糖基-(1→3)-α-D-鼠李糖基-(1→4)-α-D-半乳糖的首次全合成,产率极高,该三糖对应于洋葱伯克霍尔德菌临床分离株脂多糖中存在的O-多糖的重复单元1。该方法包括基于D-鼠李糖基三氯乙酰亚胺酯供体12和14的两次连续糖基化反应。寡糖5已通过光化学偶联或与非天然氨基酸衍生物的交叉复分解反应进一步官能化。现在已可获得三糖基氨基酸16和17,目的是制备一种新型的基于合成碳水化合物的疫苗。